Quest Diagnostics Reports First Quarter 2022 Financial Results; Raises Guidance for Full Year 2022

Go back to Quest Diagnostics Reports First Quarter 2022 Financial Results; Raises Guidance for Full Year 2022
Quest Diagnostics (NYSE: DGX) Delayed: 245.58 -1.87 (0.76%)
Previous Close $247.45    52 Week High $86.85 
Open $246.52    52 Week Low $59.66 
Day High $247.63    P/E 46.25 
Day Low $244.89    EPS $5.31 
Volume 649,339